Navigation Links
RNA snippets control protein production by disabling mRNAs
Date:8/16/2010

FINDINGS: Short pieces of RNA, called microRNAs, control protein production primarily by causing the proteins' RNA templates (known as messenger RNA or mRNA) to be disabled by the cell, according to Whitehead Institute scientists.

RELEVANCE: Researchers have known that mammalian microRNAs control protein production by causing the mRNAs to degrade, but they have wondered how much additional effects microRNAs impart by jamming the process that translates mRNAs into proteins. These results from a genome-wide study indicate that scientists can accurately study microRNA function and corresponding gene targets through examination of mRNA levels, which is easier than examining protein levels.

CAMBRIDGE, Mass. (August 16, 2010) Short pieces of RNA, called microRNAs, control protein production by causing the proteins' RNA templates (known as messenger RNA or mRNA) to be disabled by the cell, according to Whitehead Institute scientists.

Researchers have known that mammalian microRNAs control protein production by causing the mRNAs to degrade but they have wondered how much additional effects microRNAs impart by jamming the process that translates mRNAs into proteins.

For Whitehead Institute Member David Bartel, his lab's genome-wide research helps answer this question and will serve as a foundation for future research.

"These results reveal the ultimate outcome of microRNA regulation of many genes and provide a framework for us to think about how microRNAs are acting," says Bartel. "Also, we're more confident that you can learn which genes are regulated by a microRNA simply by looking at the mRNA levels, which is much easier to do than looking at protein levels."

This is the first time regulation of so many natural targets of microRNAs has been studied in such exacting detail. The Bartel lab's results are published this week in Nature.

A cell uses each microRNA to dampen the protein production of hundreds of target mRNAs, thereby fine-tuning the cell's protein output. To create a protein, a cell uses an RNA template that is copied from a gene. A cellular machine called a ribosome then translates this mRNA template into a chain of amino acids to form the protein. Until now, researchers were unsure where in this process microRNAs actthrough elimination of mRNA targets or through interference with mRNA-to-amino acid translation without much change in the mRNA.

To date, some researchers have relied mostly on highly sensitive mRNA assays to study the effects of microRNAs. Because these assays measure only mRNA levels and not protein levels, researchers worried that any microRNA activity that reduced translation without reducing the mRNA would be missed, potentially skewing results.

To determine microRNAs' effects on translation and mRNA levels, Huili Guo, a graduate student in the Bartel lab, performed genome-wide ribosome profiling of human and mouse cells. This test provides a snapshot of whether or not ribosomes are sitting on the mRNA templates. The presence of ribosomes on the mRNA indicates that the mRNA is being translated.

Guo then measured the levels of mRNAs in the cell. By accounting for the change in the amount of targeted mRNAs, she could derive the microRNAs' effects at the translation level.

If microRNAs only disrupt translation, then targeted mRNA levels should be similar to those seen in controls. Also, the ribosome profile should show far fewer ribosomes on the targeted mRNAs as a result of interrupted translation. However, Guo found that the levels of the targeted mRNAs all decreased. Although the ribosome profiling indicated that translation was also slightly reduced on these mRNAs, the overall reduction in protein production was primarily due to the more greatly reduced mRNA levels.

To extend her results, Guo says other cells should be tested.

"I looked at cells that were growing under normal conditions," says Guo. "But microRNAs have been linked to stress responses in some cells, so cells may act differently under those and other conditions."


'/>"/>

Contact: Nicole Giese
giese@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
Source:Eurekalert

Related biology news :

1. Newly discovered mechanism controls levels and efficacy of a marijuana-like substance in the brain
2. Artificially controlling water condensation leads to room-temperature ice
3. Children in good shape have better appetite control and energy expenditure
4. Scientists identify new potential biocontrol for skunk vine
5. Waters unexpected role in blood pressure control
6. Balanced ecosystems seen in organic ag better at controlling pests
7. Technique enables precise control of protein activity in living cells
8. Genetic septet in control of blood platelet clotting
9. Discovery of controlled swarm in bacteria
10. Experts identify biological control to contain fungus killer in Kenyas maize supply
11. Remote control for cholesterol regulation discovered in brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Who risk to be deprived of its ... report: https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG ... Fingerprint sensors using capacitive technology represent a fast growing ... forecasts an increase of 360% of the number of ... fingerprint sensor market between 2014 and 2017 (source : ...
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT ... (the "Company" or "Propellon"), a start-up created by ... anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive capital, ... program. The seed funding enables Propellon to accelerate ... the Company for financing and/or entering a strategic ...
(Date:3/22/2017)... , March 22, 2017   VWR ... provider of product and service solutions to ... it has acquired EPL Archives, Inc., an ... across the entire regulated product research, development ... document storage and ancillary services. EPL Archives ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has ... part of their live events series, “Stem Cell Therapy: The Next Phase in the ... the 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission ...
(Date:3/22/2017)... ... ... Benchworks CEO Thad L. Bench Sr. will participate in the ... San Diego. The event is a gathering of executive leadership from companies in the ... Meyer will also participate in the forum. Participants will discuss the future of the ...
Breaking Biology Technology: